14 February 2023
Catrin brings over 11 years’ experience in health economics and joins LCP from Mtech Access, a company specialising in pharmaceutical and medtech market access. There she co-led the health economics team, and her previous experience also includes roles at Parexel and Abacus International.
Catrin has expertise in economic evaluation across a wide number of disease areas, with recent work covering oncology, gastroenterology, nephrology, and mental health. Her experience spans the product lifecycle, from early economic models to global models suited for health technology assessment, as well as models developed for use with local payers.
Her work has been published across a range of disease areas, including chronic obstructive pulmonary disease (COPD), multiple sclerosis, and end-stage renal disease.
This senior appointment will further bolster the expertise of the growing Health Analytics Department, which has grown to more than 30 people since it was formed in August 2020. Maisie Borrows also joined earlier this month as a Strategic Growth Lead bringing experience from the pharmaceutical, policy and consulting space. Maisie previously worked for Novartis Innovative Medicines in the Global and Country affiliate teams, building expertise in the strategy and market access space. Maisie started her career in management consulting at PwC and worked for several years at Reform Think Tank as a health policy specialist. Maisie holds a BSc in Psychology from UCL and an MBA from IMD Business School, Switzerland.
The team’s data-driven approach combines traditional statistical and epidemiological approaches with innovative machine learning and actuarial methods with a core mission of improving the population’s health and reducing inequalities.
LCP’s Health Analytics team is led by Dr Jonathan Pearson-Stuttard, who is also chair of the Royal Society for Public Health. The team brings clarity to decision-makers in a world where health and healthcare are becoming increasingly complex. Through tackling the greatest challenges facing health systems, from ageing populations and multimorbidity to the opportunities of new medicines and technologies, we aim to help shift health systems from importers of illness to exporters of health. The team work with a range of clients across life sciences and the public sector and recently published work with NICE addressing the variation in health need in people with type 2 diabetes.
Catrin Treharne commented: “LCP’s health team is quickly becoming recognised and respected for its ability to understand the changes happening in the sector. I am looking forward to bringing my passion and expertise to the team and expanding its horizons with the pharmaceutical industry.”
Dr Jonathan Pearson Stuttard, Head of LCP’s Health Analytics team, added: “Our health and the challenges facing health systems are changing. The greatest threats are no longer single diseases, but the increasingly complex health demands from ageing populations with increasing multimorbidity. Catrin’s expertise and knowledge of health economic modelling will be invaluable in helping our clients ensure provision and access are targeted proportionately to those who need it most and the greatest returns to the wider health system.”